Scoreboard / OPCH
Option Care Health, Inc. OPCH
Week of October 1 to October 8, 2026 · Updated October 9, 2026
Setup Snapshot
The Setup in One Card
How OPCH scored, how it moved against the market, and the catalyst behind the move. A high score means the stock deserves research time, not that it is a buy.
Friday Five Score
Weekly Rank
03 of 5
Sector Trend
Neutralup 1.2 percent
Actionability
News Spike
Catalyst
AcquisitionAgreed to a 32.05 dollar per share cash buyout valuing the company near 5.8 billion dollars
Returns are measured from the Thursday, October 1 close to the Thursday, October 8 close. Benchmarks: S&P 500 +1.3% and Nasdaq Composite +1.2% for the week. Benchmark figures are official index closes; sector figures use SPDR sector ETF closes because the official S&P sector index closes for this window were not yet published at press time.
Why It Moved
The Story Behind the Move
Catalyst
A definitive agreement announced October 6 and filed as an 8-K exhibit, under which Clayton Dubilier and Rice at about 51 percent and McKesson at about 49 percent acquire the home infusion provider for 32.05 dollars a share in cash, a premium of roughly 37 percent, with closing expected in the first half of 2027. The stock went from 23.37 on October 5 to 31.00 on October 6, then 31.01 and 31.05.
Why It Mattered
Health Care rose only 1.18 percent and lagged the index, so a 37.51 percent week here is entirely company specific. Having two cash deals in one issue also shows how differently the market prices deal risk: 3.22 percent left here against 5.82 percent at PTC.
Risk Note
Only 3.22 percent of upside against roughly 25 percent of downside if the deal breaks. A private equity led buyout also carries financing risk a corporate acquirer does not, and a large distributor taking 49 percent of a national infusion network invites a closer regulatory look.
Reader Takeaway
Two cash deals announced a day apart with different spreads tell you what the market thinks the risks are worth. The wider spread is the riskier deal, not the better one.
Continue the Research
Put OPCH Back in Context
The stock page is one piece of the weekly research. Continue with the original issue, the full public ranking, or the method behind the analysis.
This page is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security.